IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAD0. A total of 21 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $8,648,000 | -2.1% | 8,500,000 | 0.0% | 0.01% | +14.3% |
| Q4 2021 | $8,837,000 | -3.8% | 8,500,000 | 0.0% | 0.01% | -12.5% |
| Q3 2021 | $9,183,000 | -1.0% | 8,500,000 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $9,276,000 | +1.3% | 8,500,000 | 0.0% | 0.01% | -11.1% |
| Q1 2021 | $9,158,000 | +69.6% | 8,500,000 | +70.0% | 0.01% | +80.0% |
| Q4 2020 | $5,399,000 | – | 5,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| K2 PRINCIPAL FUND, L.P. | 9,000 | $9,953,000 | 0.83% |
| CSS LLC/IL | 10,119,000 | $11,031,000 | 0.46% |
| DeepCurrents Investment Group LLC | 13,556,000 | $14,917,000 | 0.45% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 10,000,000 | $11,014,000 | 0.24% |
| WOLVERINE ASSET MANAGEMENT LLC | 28,592,000 | $31,218,000 | 0.24% |
| HBK INVESTMENTS L P | 14,616,000 | $15,971,000 | 0.06% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,127,000 | $2,334,000 | 0.05% |
| Verition Fund Management LLC | 3,942,000 | $4,304,000 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 10,037,000 | $10,959,000 | 0.01% |
| Calamos Advisors LLC | 2,423,000 | $2,648,000 | 0.01% |